Il mercato della diagnostica SIBO è stato valutato a 138.324,23 migliaia di dollari nel 2020 e si prevede che raggiungerà 194.604,51 migliaia di dollari entro il 2028; si prevede che crescerà a un CAGR del 4,4% dal 2021 al 2028.
La crescita eccessiva batterica dell'intestino tenue (SIBO) è comunemente osservata in presenza di uno o più fattori predisponenti condizioni. Varia notevolmente in base ai disturbi sottostanti e alle caratteristiche del microbiota dei pazienti e degli organismi. La SIBO provoca sintomi gastrointestinali simili all'IBS, che potrebbero essere asintomatici. Nei casi peggiori può sfociare in una vera e propria sindrome da malassorbimento. La presenza di SIBO viene generalmente diagnosticata con il test del respiro con idrogeno lattulosio e glucosio. Questi test sono ampiamente eseguiti in ogni contesto clinico grazie ai costi bassi, alla non invasività, alla sufficiente accuratezza e riproducibilità.
Il mercato della diagnostica SIBO è segmentato sulla base di diagnosi, tipo e geografia. In base alla geografia, il mercato è segmentato in Nord America, Europa, Asia Pacifico, Medio Oriente e Stati Uniti. Africa e America meridionale e centrale. Il rapporto offre approfondimenti e analisi approfondite del mercato della diagnostica SIBO sottolineando vari parametri quali tendenze del mercato, progressi tecnologici, dinamiche di mercato e analisi del panorama competitivo dei principali attori del mercato in tutto il mondo. Include anche l’analisi dell’impatto del COVID-19 in tutte le regioni. Si stima che il mercato avrà probabilmente un tasso di crescita più lento durante il periodo di previsione a causa delle limitazioni dei servizi sanitari e della situazione di blocco causata dalla pandemia di COVID-19.
Regioni redditizie per il mercato della diagnostica SIBOApprofondimenti di mercato
Aumento della prevalenza di soggetti irritabili Sindrome dell'intestino (IBS) e SIBO
La sindrome dell'intestino irritabile (IBS) è il disturbo gastrointestinale comunemente diagnosticato con dolore addominale e abitudini intestinali alterate con sintomi associati come gonfiore, malassorbimento e sintomi sistemici. L’incidenza dell’IBS sta aumentando a un ritmo significativo in tutto il mondo. Secondo un articolo di ricerca, "Prevalenza e onere mondiale dei disturbi gastrointestinali funzionali, risultati dello studio globale della Fondazione Roma" pubblicato da Elsevier Inc. nel 2021, la maggior parte dei paesi ha un tasso di prevalenza del 2-6%. Paesi come Giappone, Cina, Russia, Sud Africa e Stati Uniti hanno un tasso di prevalenza rispettivamente del 2,2%, 2,3%, 5,9%, 5,9% e 5,3%. La crescente prevalenza dell’IBS nel mondo è dovuta al cambiamento dello stile di vita e delle abitudini alimentari. La proliferazione batterica dell'intestino tenue (SIBO) è ampiamente associata all'IBS.
Allo stesso modo, la SIBO mostra sintomi simili all'IBS. Gli sviluppi tecnologici hanno ora consentito la diagnosi di SIBO durante la diagnosi di IBS. Pertanto, la prevalenza della SIBO è ampiamente compresa e segnalata in tutto il mondo. Ad esempio, secondo un articolo, "Small Intestinal Bacterial Overgrowth: A Case-Based Review" pubblicato sul Journal of Patient-Centered Research and Reviews (JPCRR) nel novembre 2015, è probabile che il 30-85% dei pazienti adulti con IBS sviluppi SIBO. Allo stesso modo, secondo i recenti dati pubblicati nel 2020 dall'American College of Gastroenterology, circa il 78% dei pazienti con IBS convive con SBIO; quindi, è una condizione prevalentemente valutata. Si stima pertanto che la prevalenza di IBS e SIBO aumenterà in modo significativo nel prossimo futuro, portando a un aumento delle diagnosi e alla futura crescita del mercato.
Approfondimenti basati sulla diagnosi
Basati sulla diagnosi, il mercato della diagnostica SIBO è segmentato in test del respiro, test dell'aspirato dell'intestino tenue e della coltura dei fluidi, analisi del sangue e altri. Nel 2020, il segmento dei test dell’etilometro ha detenuto la quota maggiore del mercato e si prevede che crescerà al ritmo più rapido nei prossimi anni. La crescita è attribuita ai suoi vantaggi, come la non invasività, la facilità del paziente, la semplicità e il basso costo
Mercato globale della diagnostica SIBO, per Diagnosis - 2020 e 2028Approfondimenti basati sul tipo
In base al tipo, il mercato della diagnostica SIBO è segmentato in SIBO a predominanza di idrogeno e SIBO a predominanza di metano SIBO e SIBO ricorrente. Nel 2020, il segmento SIBO a predominanza di idrogeno deteneva la quota maggiore del mercato e si prevede che lo stesso segmento crescerà al ritmo più rapido nei prossimi anni.
Approfondimenti strategici
Strategie organiche come il lancio di prodotti sono comunemente adottate dagli attori del mercato per soddisfare la mutevole domanda dei clienti e mantenere i loro servizi migliorati. Ad esempio, nel febbraio 2020, Commonwealth Diagnostics International (CDI), Inc., ha annunciato il rilancio commerciale di IBSchek, il primo test ematico per biomarcatori clinicamente validato per la sindrome dell'intestino irritabile con diarrea predominante e di tipo misto (IBS-D, IBS -M) in un nuovo kit per la raccolta capillare a domicilio.
By Diagnostics
- Breath Test
- 14C Test del respiro allo xilosio
- Test del respiro con idrogeno
- Test del respiro con acido glicocolico 14C
- Test di malassorbimento
- Piccolo Test dell'aspirato intestinale e della coltura dei fluidi
- Esame del sangue
- Altro
Per tipo
- SIBO a predominanza di idrogeno
- SIBO a predominanza di metano
- SIBO ricorrenti
Per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
- Europa
- Francia
- Germania< /li>
- Italia
- Regno Unito
- Spagna
- Resto d'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'APAC
- Medio Oriente e Stati Uniti Africa (MEA)
- Sudafrica
- Arabia Saudita
- EAU
- Resto del MEA
- America centrale e meridionale (SCAM)
- Brasile
- Argentina
- Resto dello SCAM
- Genova Diagnostics
- SIBO Diagnostics
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC
- Benessere vibrante
- Health Associates Medical Group
Profili aziendali
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Small intestinal bacterial growth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.
Key factors that are driving growth of the market are increasing incidence of IBS and SIBO and advantages offered by breath tests. However, limitation of diagnostics is a key factor restraining the market growth.
The cost is based on the type of diagnostics test. For instance, the hydrogen breath test is much cheaper than any other test. The cost of the test ranges from US$ 145–US$ 400. Likewise, the cost of endoscopy is ~US$ 135.
The List of Companies - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
- Genova Diagnostics
- SIBO Diagnostics
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC
- Vibrant Wellness
- Health Associates Medical Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)